WO2003013558A8 - Treatment of radiation-induced diarrhea with probiotics - Google Patents
Treatment of radiation-induced diarrhea with probioticsInfo
- Publication number
- WO2003013558A8 WO2003013558A8 PCT/IT2002/000494 IT0200494W WO03013558A8 WO 2003013558 A8 WO2003013558 A8 WO 2003013558A8 IT 0200494 W IT0200494 W IT 0200494W WO 03013558 A8 WO03013558 A8 WO 03013558A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probiotics
- radiation
- treatment
- induced diarrhea
- lactobacilli
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 206010012735 Diarrhoea Diseases 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000186000 Bifidobacterium Species 0.000 abstract 1
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 210000004347 intestinal mucosa Anatomy 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002329043A AU2002329043A1 (en) | 2001-07-30 | 2002-07-26 | Treatment of radiation-induced diarrhea with probiotics |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30811701P | 2001-07-30 | 2001-07-30 | |
US60/308,117 | 2001-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003013558A1 WO2003013558A1 (en) | 2003-02-20 |
WO2003013558A8 true WO2003013558A8 (en) | 2003-08-14 |
Family
ID=23192625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT2002/000494 WO2003013558A1 (en) | 2001-07-30 | 2002-07-26 | Treatment of radiation-induced diarrhea with probiotics |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR034920A1 (en) |
AU (1) | AU2002329043A1 (en) |
WO (1) | WO2003013558A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018112739A1 (en) * | 2016-12-20 | 2018-06-28 | 深圳华大基因研究院 | Bifidobacterium pseudocatenulatum, culture method therefor and application thereof |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1481681A1 (en) * | 2003-05-30 | 2004-12-01 | Claudio De Simone | Lactic acid bacteria combination and compositions thereof |
FR2875406B1 (en) * | 2004-09-21 | 2007-01-05 | Danisco | STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES AT THE GASTROINTESTINAL SYSTEM LEVEL |
WO2008064521A1 (en) * | 2006-11-30 | 2008-06-05 | Pharmapep Research & Development (Shenzhen) Co., Ltd. | Lactobacillus fermentum cms-h002 and use thereof |
EP2251019B1 (en) * | 2008-01-15 | 2013-05-22 | Sapporo Breweries Limited | Agent for prevention of alcoholic hepatopathy |
FI20096400A0 (en) * | 2009-12-28 | 2009-12-28 | Suomen Punainen Risti Veripalv | Use of blood group status I |
EP2228067B1 (en) * | 2010-02-22 | 2013-12-11 | LR Health & Beauty Systems GmbH | Probiotic compound and use of same |
KR102157718B1 (en) * | 2010-07-26 | 2020-09-18 | 큐 바이올로직스 인코포레이티드 | Immunogenic anti-inflammatory compositions |
CN104398538A (en) * | 2014-10-28 | 2015-03-11 | 大连医科大学 | Composite probiotics preparation for mitigating chemotherapy side effect |
CN112236154B (en) * | 2018-05-31 | 2024-10-18 | 深圳华大生命科学研究院 | A composition and its application |
CN111248443A (en) * | 2020-03-10 | 2020-06-09 | 安徽大学 | A kind of synbiotic composition with improving ulcerative colitis and its preparation and application |
CN117603842B (en) * | 2023-10-17 | 2024-07-05 | 健合香港有限公司 | Composite microbial agent and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716615A (en) * | 1992-02-10 | 1998-02-10 | Renata Maria Anna Cavaliere Vesely | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
IT1307850B1 (en) * | 1999-03-15 | 2001-11-19 | Italmed Di Galli Giovanna E Pa | PHARMACEUTICAL COMPOSITION BASED ON LACTIC FERMENTS AND NON-ABSORBABLE CARBOHYDRATIN CONTAINING A CALCIUM SALT AND AN ALUMINUM SALT |
-
2002
- 2002-07-26 AU AU2002329043A patent/AU2002329043A1/en not_active Abandoned
- 2002-07-26 WO PCT/IT2002/000494 patent/WO2003013558A1/en not_active Application Discontinuation
- 2002-07-29 AR ARP020102846A patent/AR034920A1/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018112739A1 (en) * | 2016-12-20 | 2018-06-28 | 深圳华大基因研究院 | Bifidobacterium pseudocatenulatum, culture method therefor and application thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2002329043A1 (en) | 2003-02-24 |
WO2003013558A1 (en) | 2003-02-20 |
AR034920A1 (en) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0861905A3 (en) | Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system | |
WO2000072855A3 (en) | Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria | |
WO2002060276A8 (en) | Combination of probiotics | |
BR0211441A (en) | Lactobaciillus salivarius strains probiotics | |
WO2003033681A3 (en) | Composition comprising a lactobacillus pentosus strain and uses thereof | |
CA2254548A1 (en) | Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections | |
WO2003013558A8 (en) | Treatment of radiation-induced diarrhea with probiotics | |
TR200101699T2 (en) | Oral lactobacilli application for the prevention and treatment of urogenital infections | |
HUP0100428A3 (en) | Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain | |
EP1143985A3 (en) | Use of lactobacillus salivarius | |
WO2005063200A3 (en) | Probiotic tablet formulations | |
GB0027761D0 (en) | Nutritional composition for an immune condition | |
MXPA04005346A (en) | Use of micro-organisms for a directed delivery of substances to specific parts of the gut. | |
CA2258503A1 (en) | Lectin compositions and uses thereof | |
MY140870A (en) | Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein | |
ATE221783T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILLUS PLANTARUM AND ARGININE | |
CA2294670C (en) | Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora | |
CA2388952A1 (en) | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis | |
AU2001296939A1 (en) | Oral delivery method and composition for solid medications or dietary supplements in the form of solid particles | |
EP1405641A3 (en) | Pharmaceutical and/or nutraceutical composition comprising a combination of probiotic non sporogenic microorganisms and spores of Bacillus subtilis and/or Bacillus clausii | |
EE200300220A (en) | Method for screening probiotic strains of the Bifidobacterium family | |
MD1853G2 (en) | Microbial eubiotic preparation for prophylaxis and treatment of the intestinal disbacteriosis | |
IT1274733B (en) | Strain of the genus Lactobacillus of human origin and its uses | |
HK1031685A (en) | Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 08/2003 UNDER (30) REPLACE "06/308,117" BY "60/308,117" |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |